title: Practical treatment strategies for patients with Alzheimer's disease.
abstract: With the "baby boomers" entering retirement and beyond and the life expectancy of the entire population increasing, the burden of Alzheimer's Disease (AD) grows alarmingly greater. Over 5 million people in the United States currently have AD, and that number could triple by 2050. The financial impact of caring for these patients is substantial. Estimates of direct and indirect costs are as high as $148 billion per year. In addition to its substantial economic impact, AD has devastating effects on patients and their families. Alzheimer's disease begins with gradual memory loss and progresses to personality change, behavioral disturbance, loss of executive function, and loss of the ability to perform basic activities of daily living, including eating, walking, dressing, and grooming. These impairments strain families and caregivers and create challenges to the care and safety of the patient as well as threaten the health and well-being of the caregiver. As the number of patients diagnosed with AD increases, there is an ever-growing need for early diagnosis, which often is first observed in the primary care setting. While AD cannot be reversed or stopped, disease progression can be delayed and quality of life enhanced with early diagnosis and treatment. Early and accurate diagnosis has become increasingly important and will become even more so with the anticipated new generation of medications. Though several consensus statements on diagnosis and treatment of AD have been developed, few primary care physicians routinely follow evidence-based guidelines in their clinical practices. A 2006 survey conducted by the American Academy of Family Physicians identified a moderate to high level of need for education on AD in a majority of respondents. This article illustrates the primary care management of AD beginning with diagnosis and concluding with autopsy. Enhancing diagnostic and treatment skills in primary care will promote earlier diagnosis, improved patient management, and ongoing research into this increasingly important dilemma of aging.
authors.affiliation: Neuropsychiatric Institute, University of Utah School of Medicine, Salt Lake City, UT USA.
authors.forename: Daniel D
authors.initials: DD
authors.lastname: Christensen
authors.forename: Peter
authors.initials: P
authors.lastname: Lin
mesh_terms: D000367:Age Factors; D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D001344:Autopsy; D017028:Caregivers; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D018450:Disease Progression; D005194:Family Practice / Q000379:methods; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008403:Mass Screening; D008609:Mental Status Schedule; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods; D011595:Psychomotor Agitation / Q000150:complications / Q000188:drug therapy; D012106:Research; D012944:Social Support
chemical_list: D002800:Cholinesterase Inhibitors